AREC — Arecor Therapeutics Share News
0.000.00%
- £23.60m
- £17.57m
- £1.71m
RCS - Arecor Therapeutics - Upcoming conference attendance
Arecor Therapeutics - Posting of Annual Report and Notice of AGMm
Arecor Therapeutics - Final Results
Arecor Therapeutics - Notice of FY25 Results
RCS - Arecor Therapeutics - Arecor to present at Oppenheimer conference
UK's Arecor Therapeutics 2025 revenue falls due to Tetris Pharma
Arecor Therapeutics - Holding(s) in Company
Arecor Therapeutics - Holding(s) in Company
Arecor Therapeutics - Directorate Changes
Brief: Arecor Therapeutics Announces Royalty Financing Agreement With Ligand To Raise Up To $11 Mln
Brief: Arecor Therapeutics H1 Net Income GBP -2.5 Million
Arecor Therapeutics - Interim results for the six months to 30 June 2025
Arecor Therapeutics - Notice of Interim Results
Arecor Therapeutics - Positive FDA Feedback on Phase 2 Study Design
Arecor Therapeutics - Holding(s) in Company
RCS - Arecor Therapeutics - Arecor Establishes New Scientific Advisory Board
Arecor Therapeutics - Grant of Options and PDMR Dealing
Arecor Therapeutics - Non-Executive Director Board Change
Arecor Therapeutics - Director/PDMR Dealing